Tissue Eng Part C Methods. 2016 Dec 22. doi: 10.1089/ten.TEC.2016.0404. [Epub ahead of print]

Mimicking the Acute myeloid leukemia niche for molecular study and drug screening.

Houshmand M¹, Soleimani M^2,3, Atashi A⁴, Saglio G⁵, Abdollahi M⁶, Nikougoftar Zarif M⁷.

Abstract

Bone marrow niche is a major contributing factor in leukemia development and drug resistance in Acute Myeloid Leukemia (AML) patients. Although mimicking leukemic bone marrow niche relies on two dimensional (2D) culture conditions, it can't recapitulate complex bone marrow structure which causes introduction of different three dimensional (3D) scaffolds. Simultaneously, microfluidic platform by perfusing medium culture mimic interstitial fluid flow, along with 3D scaffold would help for mimicking bone marrow microenvironment. In this study TF-1 cells were co cultured with Bone Marrow Mesenchymal stem cells (BM-MSCs) in 2D and 3D microfluidic devices. Phenotype maintenance during cell culture and proliferation rate was assayed and confirmed by cell cycle analysis. Morphology of cells in 2D and 3D culture conditions was demonstrated by scanning electron microscopy. After these experiments, Drug screening was performed by applying Azacitidine and Cytarabine and cytotoxicity assay and quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) for B-Cell Lymphoma 2 (BCL2) were done to compare drug resistance in 2D and 3D culture conditions. Our result show Leukemic cells in 3D microfluidic device retaining their phenotype and proliferation rate was significantly higher in 3D culture condition in comparison to 2D culture condition (P-value<0.05) which was confirmed by cell cycle analysis. Cytotoxicity assay also illustrated drug resistance in 3D culture condition and qRT-PCR demonstrated higher BCL2 expression in 3D microfluidic device in contrast to 2D microfluidic device (P-value<0.05). On balance, mimicking bone marrow niche would help the target therapy and specify the role of niche in development of leukemia in AML patients.